#LiverHealth nejm.org/doi/full/10.10 @NEJM @novonordisk Please please rebrand Wegovy for MASH once its approved so my insurance will cover it
Health Canada approved on Tuesday the first generic version of Danish drugmaker Novo Nordisk's Ozempic drug
Semaglutide biosimilars are expected to achieve regulatory approval and market launch beginning in 2031 to 2032 following expiration of Novo Nordisk's patent protections
Indications / Uses Semaglutide is used to help adults with obesity, or adults with overweight who also have weight-related medical problems, to effectively lose excess body weight and maintain the weight loss
Can You Overdose on Mounjaro
Viral titers plateaued during the first 3 days post-infection (6.9 9.9 10 2 , 6.0 7.5 10 2 , 6.0 6.6 10 2 nsp14 copies/ng of RNA on D1, D2, and D3, respectively) and then progressively decayed close to the limit of detection by D6